Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6073532 | Journal of the American Academy of Dermatology | 2014 | 8 Pages |
Abstract
Dose escalation optimizes durability of infliximab. The probability of maintaining response is enhanced by concomitant methotrexate and increasing the infusion frequency before increasing the dose.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Adam J. BA, Cindy L. Tsui, Gillian M. MD, Mark G. MD, Jacob O. MD,